| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Health literacy and cancer communication.
|
CA Cancer J Clin
|
2002
|
4.66
|
|
2
|
IGF-I and breast cancer: a meta-analysis.
|
Int J Cancer
|
2004
|
2.03
|
|
3
|
Is percutaneous nephrolithotomy in solitary kidneys safe?
|
Urology
|
2013
|
1.55
|
|
4
|
Percutaneous nephrolithotomy in England: practice and outcomes described in the Hospital Episode Statistics database.
|
BJU Int
|
2013
|
1.53
|
|
5
|
Preventing familial amyotrophic lateral sclerosis: is a clinical trial feasible?
|
J Neurol Sci
|
2006
|
1.51
|
|
6
|
Hepcidin regulation of ferroportin 1 expression in the liver and intestine of the rat.
|
Am J Physiol Gastrointest Liver Physiol
|
2003
|
1.43
|
|
7
|
Defining the learning curve for percutaneous nephrolithotomy.
|
J Endourol
|
2005
|
1.42
|
|
8
|
Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer.
|
Cancer Res
|
2007
|
1.38
|
|
9
|
Incidental renal stones in potential live kidney donors: prevalence, assessment and donation, including role of ex vivo ureteroscopy.
|
BJU Int
|
2012
|
1.32
|
|
10
|
Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
|
Clin Cancer Res
|
2004
|
1.31
|
|
11
|
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes.
|
Neurosurgery
|
2012
|
1.27
|
|
12
|
Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
|
J Exp Clin Cancer Res
|
2010
|
1.20
|
|
13
|
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.
|
PLoS One
|
2013
|
1.19
|
|
14
|
Primary plasma cell leukemia: report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature.
|
Am J Hematol
|
2005
|
1.16
|
|
15
|
Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma.
|
Mol Cancer Ther
|
2009
|
1.10
|
|
16
|
RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
|
J Cell Biochem
|
2006
|
1.07
|
|
17
|
Iron Imports. V. Transport of iron through the intestinal epithelium.
|
Am J Physiol Gastrointest Liver Physiol
|
2006
|
1.06
|
|
18
|
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I trial, cervical microinjection, and final surgical safety outcomes.
|
Neurosurgery
|
2014
|
1.04
|
|
19
|
Multimodal management of urolithiasis in renal transplantation.
|
BJU Int
|
2005
|
1.03
|
|
20
|
Race/Ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.99
|
|
21
|
Case report: percutaneous nephrolithotomy for a stone on a Hem-o-lok clip.
|
J Endourol
|
2008
|
0.98
|
|
22
|
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP.
|
Neurology
|
2013
|
0.95
|
|
23
|
Trogocytosis of MHC-I/peptide complexes derived from tumors and infected cells enhances dendritic cell cross-priming and promotes adaptive T cell responses.
|
PLoS One
|
2008
|
0.95
|
|
24
|
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS.
|
Amyotroph Lateral Scler
|
2012
|
0.95
|
|
25
|
The phenotypic radiation resistance of CD44+/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling.
|
PLoS One
|
2011
|
0.94
|
|
26
|
Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
0.94
|
|
27
|
Interactions between ferroportin and hephaestin in rat enterocytes are reduced after iron ingestion.
|
Gastroenterology
|
2011
|
0.93
|
|
28
|
Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
|
Cancer Chemother Pharmacol
|
2008
|
0.93
|
|
29
|
Three 'Pages' in a chapter of accidents.
|
Nephrol Dial Transplant
|
2003
|
0.92
|
|
30
|
Down regulation of PSA by C/EBPalpha is associated with loss of AR expression and inhibition of PSA promoter activity in the LNCaP cell line.
|
BMC Cancer
|
2006
|
0.89
|
|
31
|
Commercial insurance triples chances of breast cancer survival in a public hospital.
|
Breast J
|
2013
|
0.88
|
|
32
|
The transcytosis of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium.
|
Am J Physiol Gastrointest Liver Physiol
|
2002
|
0.88
|
|
33
|
Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.
|
J Clin Pharmacol
|
2014
|
0.87
|
|
34
|
Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis.
|
PLoS One
|
2013
|
0.87
|
|
35
|
Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced-stage head and neck squamous cell carcinoma.
|
Head Neck
|
2010
|
0.86
|
|
36
|
In prostate cancer cells the interaction of C/EBPalpha with Ku70, Ku80, and poly(ADP-ribose) polymerase-1 increases sensitivity to DNA damage.
|
J Biol Chem
|
2006
|
0.86
|
|
37
|
In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
|
Prostate
|
2009
|
0.85
|
|
38
|
DMT1 (IRE) expression in intestinal and erythroid cells is regulated by peripheral benzodiazepine receptor-associated protein 7.
|
Am J Physiol Gastrointest Liver Physiol
|
2012
|
0.85
|
|
39
|
Stable expression of C/EBPalpha in prostate cancer cells down-regulates metallothionein and increases zinc-induced toxicity.
|
Prostate
|
2005
|
0.83
|
|
40
|
A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.
|
Am J Hematol
|
2012
|
0.83
|
|
41
|
Association of core-binding factor β with the malignant phenotype of prostate and ovarian cancer cells.
|
J Cell Physiol
|
2010
|
0.83
|
|
42
|
Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.
|
J Am Coll Surg
|
2010
|
0.83
|
|
43
|
Flexible ureterorenoscopy (URS) for lower pole calculi.
|
BJU Int
|
2012
|
0.82
|
|
44
|
Priming of immune responses against transporter associated with antigen processing (TAP)-deficient tumours: tumour direct priming.
|
Immunology
|
2009
|
0.81
|
|
45
|
Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells.
|
Prostate
|
2013
|
0.81
|
|
46
|
Improving the interpretation of ureteroscopic biopsies: use of Bouin's fixative.
|
BJU Int
|
2011
|
0.81
|
|
47
|
Generalized tetanus despite prior vaccination and a protective level of anti-tetanus antibodies.
|
Am J Med Sci
|
2010
|
0.80
|
|
48
|
A randomized controlled trial of human versus robotic and telerobotic access to the kidney as the first step in percutaneous nephrolithotomy.
|
Comput Aided Surg
|
2005
|
0.80
|
|
49
|
Hypoxia-inducible factor-2α and iron absorptive gene expression in Belgrade rat intestine.
|
Am J Physiol Gastrointest Liver Physiol
|
2011
|
0.80
|
|
50
|
Anticancer activity of the iron facilitator LS081.
|
J Exp Clin Cancer Res
|
2011
|
0.80
|
|
51
|
Effect of B7.1 costimulation on T-cell based immunity against TAP-negative cancer can be facilitated by TAP1 expression.
|
PLoS One
|
2009
|
0.79
|
|
52
|
PET imaging today: contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas.
|
J La State Med Soc
|
2006
|
0.79
|
|
53
|
Management of cystinuric patients: an observational, retrospective, single-centre analysis.
|
Urol Int
|
2008
|
0.78
|
|
54
|
In vivo survivors of transformed mouse ovarian surface epithelial cells display diverse phenotypes for gene expression and tumorigenicity.
|
Tumour Biol
|
2008
|
0.78
|
|
55
|
ALS Untangled No. 20: the Deanna protocol.
|
Amyotroph Lateral Scler Frontotemporal Degener
|
2013
|
0.77
|
|
56
|
Treatment of acute myeloid leukemia in a Jehovah's Witness.
|
Ann Hematol
|
2006
|
0.77
|
|
57
|
MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
|
Mol Cancer
|
2007
|
0.77
|
|
58
|
NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.77
|
|
59
|
Iron facilitator LS081 reduces hypoxia-inducible factor-1α protein and functions as anticancer agent in hepatocellular carcinoma.
|
Cancer Sci
|
2012
|
0.76
|
|
60
|
The evolution of ureteroscopy.
|
Int J Clin Pract
|
2007
|
0.75
|
|
61
|
Kidney stones.
|
BMJ Clin Evid
|
2009
|
0.75
|
|
62
|
Findings that hospital factors are surrogate for disparities are misleading.
|
J Clin Oncol
|
2009
|
0.75
|
|
63
|
Spontaneous passage of large ureteric stone in a child.
|
N Z Med J
|
2008
|
0.75
|
|
64
|
Kidney stones.
|
BMJ Clin Evid
|
2007
|
0.75
|
|
65
|
The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation.
|
Acta Haematol
|
2015
|
0.75
|
|
66
|
Controlled intermittent asystole cardiac therapy induced by pharmacologically potentiated vagus nerve stimulation in normal and hibernating myocardium.
|
Ann Thorac Surg
|
2003
|
0.75
|